Carregant...

Crizotinib-associated toxic epidermal necrolysis in an ALK-positive advanced NSCLC patient

Crizotinib is an oral small-molecule inhibitor of anaplastic lymphoma kinase (ALK) tyrosine-kinase that has been approved for treating patients with advanced echinoderm microtubule associated protein like 4-ALK rearranged non-small-cell lung cancer (NSCLC). Toxic epidermal necrolysis (TEN) is a rare...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Clin Oncol
Autors principals: Yang, Shaoyu, Wu, Liming, Li, Xin, Huang, Jie, Zhong, Jianbo, Chen, Xueqin
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2018
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5795818/
https://ncbi.nlm.nih.gov/pubmed/29456853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2018.1553
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!